News New paediatric use for Allergan's biosimilar-threatened Boto... Allergan’s Botox has another clinical use after the FDA granted approval for children with upper limb spasticity.
News FDA approves Herceptin biosimilar as US patent expires The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry.
News SMC approves medicines for breast cancer, skin cancer, schiz... The Scottish Medicines Consortium (SM
Views & Analysis Collaborating to fight NASH Eric Hughes, Global Development Unit head at Novartis for Immunology, Hepatology & Dermatology, believes that collaboration is going to be key to finally finding a treatment for non
News Discontent at Allergan over CEO's chairman role - report There is discontent among Allergan’s shareholders over CEO Brent Saunders’ dual role as chairman, according to press reports.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
